|
|||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||||||
Press Releases See our recent press releases.
Features/Perspectives Hear and see company leadership, industry experts and patients discuss key issues and share their stories.
Media Contacts Find out who to contact if you are a member of the media.
Fact Sheets and Information Resources See additional resources for the media such as fact sheets, press kits and other information.
Corporate Overview Read a brochure about our company.
Positions / Policies Read our positions on various topics.
Baxter in the News Read recent news coverage and learn about events and recognition.
Sustainability Read our Sustainability Report and the latest news about our initiatives.
Investor Relations Read our annual report, proxy statements and other financial information.
Press Releases
Baxter's Board of Directors Declares Quarterly Dividend
Shareholders Re-elect Directors and Ratify Auditor at Annual Meeting
DEERFIELD, Ill., May 6, 2008 – The Board of Directors of Baxter International Inc. (NYSE:BAX) today announced a quarterly dividend and votes taken at the company’s Annual Meeting of Shareholders held earlier today.
Baxter’s Board of Directors declared a quarterly dividend of $0.2175 per share of Baxter common stock. This payment represents a continuation of the current rate. The quarterly dividend is payable on July 1, 2008 to shareholders of record as of June 10, 2008.
At its Annual Meeting of Shareholders held today in Chicago, Baxter shareholders re-elected five members of the company’s board of directors -- Wayne T. Hockmeyer, Ph.D., Joseph B. Martin, M.D., Ph.D., Robert L. Parkinson, Jr., Thomas T. Stallkamp and Albert P.L. Stroucken -- for a term of three years. Shareholders also ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Baxter.
A webcast replay of Baxter's Annual Meeting of Shareholders can be accessed from a link on the company's website at www.baxter.com. Please visit Baxter's website for more information regarding this and future investor events and webcasts.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
| For More Information | |
| Media Contact: Deborah Spak, (847) 948-2349 |
Investor Contacts: Mary Kay Ladone, (847) 948-3371 Clare Trachtman, (847) 948-3085 |
